PTIX

Protagenic Therapeutics, Inc. PTIX

PTIX
Protagenic Therapeutics, Inc. LIPO
Lipella Pharmaceuticals Inc. ARTL
Artelo Biosciences, Inc. GTBP
GT Biopharma, Inc. VRAX
Virax Biolabs Group Limited AZTR
Azitra, Inc. SPRC
SciSparc Ltd. PBM
Psyence Biomedical Ltd. INDP
Indaptus Therapeutics, Inc. NKGN
NKGen Biotech, Inc. Common Stock

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode PTIX LIPO ARTL GTBP VRAX AZTR SPRC PBM INDP NKGN
6M -11.11 % -75.10 % -27.84 % -67.40 % -37.84 % -66.70 % -24.47 % 8.92 % -71.30 % -84.13 %
YTD -55.98 % -81.13 % -35.78 % -75.05 % -71.03 % -76.15 % -47.94 % -75.69 % -83.79 % -97.11 %
1Y -59.13 % -83.61 % -45.74 % -63.33 % -60.24 % -80.60 % -7.94 % -93.87 % -90.31 % -92.74 %
3Y -90.48 % -89.57 % -78.46 % -98.53 % -96.21 % -99.93 % -99.19 % -99.91 % -92.67 % -99.65 %
5Y -97.47 % -89.57 % -92.55 % -99.39 % -99.65 % -99.93 % -99.83 % -99.91 % -99.31 % -99.65 %
10Y -97.47 % -89.57 % -99.00 % -100.00 % -99.65 % -99.93 % -99.83 % -99.91 % -99.97 % -99.65 %
From the beginning -97.47 % -89.57 % -99.00 % -100.00 % -99.65 % -99.93 % -99.83 % -99.91 % -99.97 % -99.65 %

Dividend

Protagenic Therapeutics, Inc.